Prostate cancer has been of the major areas of research for radioligand therapies. Last year, Novartis officials estimated that the March 28, 2025, FDA approval for Pluvicto in metastatic ...

A plant-based diet combined with probiotics reduces PSA increase in men and lowers prostate cancer risk by 3x.

A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive prostate cancer and personalise screening strategies.

A supplement made from broccoli, green tea, and turmeric has slowed the rise of a prostate cancer blood marker in men monitored for early disease. That slowdown reframes how long some patients may ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients. The study published ...

Scientists have taken a first step toward improving those problematic PSA tests for prostate cancer, by mixing in some genetic information that might help tell which men really need a biopsy. The ...

A study on non-coding RNA (Ribonucleic Acid) from prostate cancer patients has identified a series of new prostate cancer markers which can be found in urine. Combining these RNA markers into a single ...

The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...

They retain early prostate cancer genomic aberrations and often acquire tumor suppressor losses (eg, TP53, RB1) and distinct changes in their epigenetic and transcriptomic landscape. 71 The most ...

Guy Griffiths was diagnosed after he requested a prostate specific antigen (PSA) test from his GP.

Here’s what actually happens in a prostate cancer screening - While many people are familiar with mammograms and smear tests, ...